What researchers published on Triple-negative breast cancer
3,459 papers, newest first.
Showing 20 of 3,459
Not labelled yetComprehensive characterization of the cellular and molecular consequences of LCN2 loss in MDA-MB-231 triple-negative breast cancer cells.Frontiers in cell and developmental biology
Not labelled yetClaims-defined adrenal insufficiency, hypothyroidism, and type 1 diabetes after immune checkpoint inhibitor initiation in patients with triple-negative breast cancer in Japan.Breast cancer (Tokyo, Japan)
ReviewGlutamine as a context-dependent regulator controlling metabolism and immunity in triple-negative breast cancer.Cell communication and signaling : CCS
Meta-analysisReal-world effectiveness and safety of neoadjuvant pembrolizumab in early-stage triple-negative breast cancer: a systematic review and meta-analysis.BMC cancer
Not labelled yetAnalyzing per- and polyfluoroalkyl substances (PFAS) in triple-negative breast cancer (TNBC): an integrative transcriptomic and computational study.Cell biology and toxicology
Not labelled yetAntibody-drug conjugates therapy for triple-negative breast cancer: a systematic review and meta-analysis.Frontiers in medicine
Not labelled yetCD39-associated myeloid-T-cell coordination within an immunoregulatory neighborhood linked to treatment resistance in triple-negative breast cancer.Breast cancer research : BCR
Not labelled yetBifunctional EGFR/CD44-Targeted Diabody-Decorated Doxorubicin-Loaded Solid Lipid Nanoparticles for Targeted Therapy in Triple-Negative Breast Cancer.Advanced pharmaceutical bulletin
Not labelled yetEgonol restores tamoxifen sensitivity via the miR-3529-5p-CLOCK axis in triple-negative breast cancer cells.Fitoterapia
Not labelled yetEffect of Exosome-loaded hsa-miR-203a-3p on Triple Negative Breast Cancer Cell Viability, Migration, and Gene Targets: In Silico and In Vitro Study.Advanced pharmaceutical bulletin
Not labelled yetCD97 Modulates M1-Like Macrophage Activation and Function to Influence the Immune Microenvironment and Tumor Progression in Triple-Negative Breast Cancer.Journal of inflammation research
Not labelled yetCircEML1 upregulates BTG2 to suppress the progression of triple-negative breast cancer.Biology direct
Not labelled yetBiotin-Functionalized Multi-Stimuli-Responsive Polymeric Prodrug for Receptor-Mediated and Mitochondria-Targeted Codelivery of Camptothecin and Protocatechualdehyde.Biomacromolecules
Not labelled yetTargeting CD44v3 rescues Entrectinib response in brain metastasis of triple negative breast cancer overexpressing TrkA.Signal transduction and targeted therapy
Not labelled yetDecoding neutrophil spatial heterogeneity and clinical implications in breast cancer.Cancer cell
Not labelled yetGeographical access to radiotherapy and surgical treatment selection in older women with HER2-positive and triple-negative breast cancer: A real-world exploratory study.Journal of geriatric oncology
Not labelled yetDurable Treatment-Free Remission in BRCA1-Associated Metastatic Triple-Negative Breast Cancer with Brain and Radiologically Diagnosed Hepatic Metastases: A Case Report.Oncology and therapy
ReviewBrain Metastasis of Triple-Negative Breast Cancer: Mechanisms and Emerging Therapeutic Strategies.The breast journal
Not labelled yetSubtype conversion and metastatic timing in breast cancer liver metastasis.World journal of surgical oncology
Not labelled yetNeutrophils are known by their neighbors in breast cancer.Cancer cell